Discovery on Target (DOT) is a leading conference that highlights the latest advances in drug discovery, with a particular focus on both established and emerging molecular targets that are gaining significant attention in the field. The event brings together experts to discuss cutting-edge technologies and strategies for target validation, a crucial step in the development of new therapeutic agents. These agents, ranging from small molecules to biologics, are designed to interact with specific targets, offering the potential to treat various diseases more effectively. DOT serves as a platform for sharing insights into the identification and validation of these targets, ultimately accelerating the development of novel therapies.